A high-throughput screen against pantothenate synthetase (PanC) identifies 3-biphenyl-4-cyanopyrrole-2-carboxylic acids as a new class of inhibitor with activity against Mycobacterium tuberculosis.

PloS one, Volume: 8, Issue: 11
November 7, 2013
Anuradha Kumar A, Allen Casey A, Joshua Odingo J, Edward A Kesicki EA, Garth Abrahams G, Michal Vieth M, Thierry Masquelin T, Valerie Mizrahi V, Philip A Hipskind PA, David R Sherman DR, Tanya Parish T

The enzyme pantothenate synthetase, PanC, is an attractive drug target in Mycobacterium tuberculosis. It is essential for the in vitro growth of M. tuberculosis and for survival of the bacteria in the mouse model of infection. PanC is absent from mammals. We developed an enzyme-based assay to identify inhibitors of PanC, optimized it for high-throughput screening, and tested a large and diverse library of compounds for activity. Two compounds belonging to the same chemical class of 3-biphenyl-4- cyanopyrrole-2-carboxylic acids had activity against the purified recombinant protein, and also inhibited growth of live M. tuberculosis in manner consistent with PanC inhibition. Thus we have identified a new class of PanC inhibitors with whole cell activity that can be further developed.

Courtesy of the U.S. National Library of Medicine